CClinicalTrials.gg
Active, not recruitingNCT07776106Updated Aug 24, 2026

The Perspectives of Those Who Experienced the Kahramanmaraş Earthquake

An observational study in Earthquake, sponsored by Zülal TATAR. Active, not recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-24.

Sponsored by Zülal TATAR · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
53
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study was to explore the perspectives of individuals who experienced the Kahramanmaraş earthquake through a qualitative approach.

02

Conditions studied

  • Earthquake
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Individuals over 18 years of age who have experienced an earthquake.

Inclusion criteria

  • Having experienced the Kahramanmaraş earthquake
  • Being 18 years of age or older,
  • Agreeing to participate in the study

Exclusion criteria

Exclusion Criteria:

  • The presence of medical/psychiatric conditions that may affect study measurements (e.g., neurological disorders, severe psychiatric illness)
  • Individuals with orthopedic, neurological, or other problems that developed before or due to the earthquake and that may prevent the participant from participating in the assessments
04

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
53 participants (estimated)
Patient registry
No
05

What researchers measure

Primary outcomes

  1. Open-Ended Questionnaire

    Participants will be asked 7 open-ended questions about how they were affected by the Kahramanmaraş earthquake, how their lives changed, and how they returned to their normal daily routines: What was the biggest change in your life after the earthquake? What was the most important thing that kept you going after the earthquake? What is the most important lesson you learned from your earthquake experience? What factors made it easier to return to your normal daily routine after the earthquake? What factors made it difficult to return to your normal daily routine after the earthquake? How did the earthquake affect you psychologically? How long did you stay in temporary shelter after the earthquake?

    Time frame: At baseline (Day 1)

Secondary outcomes

  1. Participant Introduction Form

    The following questions addressing the socio-demographic characteristics of the participants will be asked: Age, Gender, Height, Weight, Education level, Location during the earthquake, Was your home damaged?, Were you forced to relocate due to the earthquake?, Did you suffer any physical injuries during the earthquake?, Were any of your relatives injured?, Did you lose a first-degree relative in the earthquake?, Did you receive psychological support after the earthquake?, Did you have a disaster/emergency kit in your home before the earthquake?, Did you receive disaster training before the earthquake?

    Time frame: At baseline (Day 1)

06

Study locations

1 site
  • Pamukkale University
    Denizli, Turkey (Türkiye)
07

Registry details

Key details

Study ID
NCT07776106
Lead sponsor
Zülal TATAR
Responsible party
Zülal TATAR (Lecturer, Pamukkale University) — Sponsor-investigator
First posted
Aug 20, 2026
Start date
Jul 22, 2026
Primary completion
Sep 22, 2026 (estimated)
Completion
Dec 15, 2026 (estimated)
Last update
Aug 24, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion